ArticleJournal of medical case reports2026
Cutaneous angiosarcoma in a super-morbidly obese patient (body mass index 106.7 kg/m
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith the rising prevalence of extreme obesity, healthcare systems are increasingly confronted with patients who exceed the physical limits of standard diagnostic and therapeutic infrastructure. When body habitus exceeds the physical limitations of imaging and procedural infrastructure, timely cancer staging and intervention may become impossible, directly impacting survival. CASE PRESENTATION: We report a 54-year-old White woman (weight ≈ 280 kg, BMI 106.7 kg/m MANAGEMENT AND OUTCOME: Despite aggressive multidisciplinary intensive care, including continuous renal replacement therapy, thoracic drainage, catecholamine support, and non-invasive ventilation, diagnostic and interventional escalation remained repeatedly limited by infrastructural constraints. Owing to refractory multi-organ failure and an infaust prognosis, treatment was de-escalated to comfort-focused care. The patient died on day 24 of admission.
conclusionThis case illustrates how extreme obesity not only predisposes to lymphangiosarcoma, but may also preclude access to basic oncologic standards such as staging and operability assessment. The case highlights a critical gap in healthcare infrastructure, where patients may be systematically excluded from standard diagnostic pathways. The absence of bariatric-capable imaging and procedural infrastructure directly contributed to a loss of curative options. Healthcare systems must urgently adapt to the rising prevalence of super-morbid obesity by ensuring size-inclusive resources, or risk systematic exclusion of an expanding vulnerable population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.